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Abstract
FSH and androgen act to stimulate and maintain spermatogenesis. FSH acts directly on the Sertoli cells to stimulate germ cell number
and acts indirectly to increase androgen production by the Leydig cells. In order to differentiate between the direct effects of FSH on
spermatogenesis and those mediated indirectly through androgen action, we have crossed hypogonadal (hpg) mice, which lack
gonadotrophins, with mice lacking androgen receptors (AR) either ubiquitously (ARKO) or speciﬁcally on the Sertoli cells (SCARKO).
These hpg.ARKOand hpg.SCARKOmiceweretreated with recombinantFSH for 7 days and testicular morphologyand cell numberswere
assessed. In untreated hpg and hpg.SCARKO mice, germ cell development was limited and did not progress beyond the pachytene stage.
In hpg.ARKO mice, testes were smaller with fewer Sertoli cells and germ cells compared to hpg mice. Treatment with FSH had no effect
on Sertoli cell number but signiﬁcantly increased germ cell numbers in all groups. In hpg mice, FSH increased the numbers of
spermatogonia and spermatocytes, and induced round spermatid formation. In hpg.SCARKO and hpg.ARKO mice, in contrast, only
spermatogonial and spermatocyte numbers were increased with no formation of spermatids. Leydig cell numbers were increased by FSH
in hpg and hpg.SCARKO mice but not in hpg.ARKO mice. Results show that in rodents 1) FSH acts to stimulate spermatogenesis through
an increase in spermatogonial number and subsequent entry of these cells into meiosis, 2) FSH has no direct effect on the completion of
meiosis and 3) FSH effects on Leydig cell number are mediated through interstitial ARs.
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Introduction
Sertoli cell function and spermatogenesis are dependent
upon the actions of FSH and androgen. This is clearly
seen in hypogonadal (hpg) mice, which lack circulating
FSH and LH and are infertile with associated failure of
the germ cells to progress beyond early meiosis
(Cattanach et al. 1977). Treatment of hpg mice with
FSH stimulates germ cell proliferation, with an increase
in spermatogonial and spermatocyte numbers, and
induces spermatid formation (Singh & Handelsman
1996). This is similar to the effects of FSH in the
GNRH-immunised or hypophysectomised rat (Vihko
et al. 1991, Russell et al. 1993, McLachlan et al.
1995), and in tandem with studies on FSH receptor
knockout (FSHRKO) mice, our current understanding is
that the primary function of FSH is to maintain germ cell
numbers and to promote germ cell progression through
meiosis (Dierich et al. 1998). One major problem with
the study of FSH action in these models, however, is
dissociating the effects of FSH from those of androgen.
In early studies, the FSH preparations used contained
low levels of LH, which could induce androgen
production by the Leydig cells. Use of recombinant
FSH has overcome this problem but there remains the
issue that FSH has been shown to induce Leydig cell
function, probably indirectly through stimulation of the
Sertoli cells (Johnson & Ewing 1971, Chen et al. 1976,
Vihko et al. 1991). We have shown that FSH will
increase androgen levels in the hpg testis and that it will
induce expression of androgen-dependent Sertoli cell
genes such as Rhox5 (Abel et al. 2009). It remains likely,
therefore, that some of the effects of FSH on spermato-
genesis, seen in models such as the hpg or hypophy-
sectomised animal, are mediated indirectly through
stimulation of androgen production. To investigate the
role of androgen in mediating FSH action and to identify
the direct effects of FSH, we have generated hpg mice
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(hpg.ARKO) or speciﬁcally on the Sertoli cells
(hpg.SCARKO). Treatment of these mice with FSH allows
us to dissect the direct effects of FSH on testicular
function from those mediated by androgen action
through the Sertoli cell or other androgen-responsive
cells in the testis.
Results
Testis volume, seminal vesicle weight and testosterone
levels
Testicular volume was similar in hpg and hpg.SCARKO
mice but was signiﬁcantly reduced in hpg.ARKO mice
(Fig. 1). Treatment of the animals with FSH for 7 days
increased testis volume signiﬁcantly in all three groups.
Seminal vesicle weights were similar in hpg and
hpg.SCARKO mice, and were signiﬁcantly increased by
FSH (Table 1). The hpg.ARKO mice do not develop
seminal vesicles. Intratesticular testosterone levels were
signiﬁcantly increased in hpg mice after 7 days treatment
with FSH but were unaffected in hpg.SCARKO or
hpg.ARKO mice (Fig. 1). For comparison, intratesticular
testosteronelevelsinnormaladultmiceareabout50 pmol/
testis (Baker et al.2 0 0 3 , O’Shaughnessy et al.2 0 0 8 ).
Morphology
As described previously, and with the variation noted in
Materials and Methods, spermatogenesis in untreated
hpg mice was severely disrupted with spermatocyte
progression only as far as the pachytene stage and
no spermatids present (Fig. 2). Few Leydig cells were
apparent within the interstitial space (Fig. 2). Testes from
untreated hpg.SCARKO mice had a similar morphology
with spermatogenesis progressing to the primary sper-
matocyte stage (Fig. 2). In hpg.ARKO mice, the tubules
were smaller, and while spermatogenesis progressed to
the same stage as the hpg mice, fewer spermatocytes
were apparent. Crystalline structures with the appear-
ance of microliths were present in some tubules, as
previously reported (O’Shaughnessy et al. 2009).
Treatment of hpg mice with FSH caused an increase in
seminiferous tubule diameter (Figs 2 and 3), clear
establishment of a tubular lumen and an increase in
germ cell number (Fig. 2). In some tubules, spermato-
genesis progressed to the round spermatid stage (Fig. 2).
In hpg.SCARKO and hpg.ARKO mice, there was also an
increase in tubule diameter, although not as marked as in
the hpg (Figs 2 and 3) and, while there was a clear
increase in germ cell number, there was no apparent
progression beyond the primary spermatocyte stage.
FSH treatment caused an apparent increase in
interstitial space and cell numbers in hpg and
hpg.SCARKO mice (Fig. 2). There was no clear effect of
FSH on the interstitium of the hpg.ARKO mouse (Fig. 2).
Stereology
Sertoli cell number was similar in hpg and hpg.SCARKO
mice but was signiﬁcantly reduced in hpg.ARKO mice
(Fig. 3). Treatment with FSH had no signiﬁcant effect on
Sertoli cell number in anygroup. Leydig cell number was
similar in hpg and hpg.SCARKO mice but was slightly
reduced in hpg.ARKO mice compared with the
hpg.SCARKO (Fig. 3). Treatment with FSH increased
Leydig cell number in hpg and hpg.SCARKO mice but
had no effect in hpg.ARKO mice.
Figure 1 Effect of FSH on (A) testis volume and (B) intratesticular
testosterone in hpg, hpg.SCARKO and hpg.ARKO mice. In (A), data
wereanalysed bytwo-factor ANOVA followed by t-tests as describedin
Materials and Methods. An interaction indicates that the effect of FSH
was signiﬁcantly different in the three animal groups. In untreated
animals, groups with different letter superscripts were signiﬁcantly
different (P!0.05). If FSH had a signiﬁcant effect on a particular animal
group, this is indicated by *. MeanGS.E.M. is shown. Animal numbers,
hpg nZ7; hpgCFSH nZ3; hpg.SCARKO nZ5; hpg.SCARKOCFSH
nZ4; hpg.ARKO nZ3; hpg.ARKOCFSH nZ3. In (B), individual values
from each animal are shown. The limit of detection of the assay is
indicated by the broken horizontal line. Data were analysed by the
Kruskal–Wallis and Mann–Whitney tests. FSH had a signiﬁcant effect
(P!0.05) in the hpg mice but had no effect in the other animal groups.
Table 1 Seminal vesicle (SV) weights in hpg and hpg.SCARKO mice.
SV weight (mg)
Group Control plus FSH
hpg 2.94G0.16 (nZ13) 3.40G0.13 (nZ30)
hpg.SCARKO 3.18G0.15 (nZ12) 3.65G0.16 (nZ19)
There was no signiﬁcant difference between SV weights in hpg and
hpg.SCARKO mice, but there was a signiﬁcant (P!0.05) effect of FSH
in both groups. MeanGS.E.M. is reported.
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numbers were similar in hpg and hpg.SCARKO mice but
were signiﬁcantly reduced in hpg.ARKO mice (Fig. 4).
Treatment with FSH increased total germ cell number in
all three groups by three- to fourfold (Fig. 4). Statistical
analysis showed no interaction between the effects of
FSH and animal phenotype, indicating that the effect
of FSH was similar in all three groups. Further analysis of
germ cell types showed that spermatogonial and
spermatocyte numbers were increased by FSH in all
groups with no signiﬁcant interaction. As indicated
above, FSH treatment induced development of round
spermatids only in hpg mice and not in hpg.SCARKO or
hpg.ARKO mice.
Discussion
The function that FSH plays in the regulation of
spermatogenesis in rodents and higher mammals has
been the subject of considerable study, and continuing
uncertainty, since the early pioneering work in the
1930s, which showed that FSH could partially restore
spermatogenesis in rats after hypophysectomy (Greep
et al. 1936). Problems with LH contamination of FSH
preparations limited the progress for a number of years,
but a major development in our understanding of FSH
action in the rodent came with the generation of mice
lacking FSH (FSHbKO) or the FSH receptor (FSHRKO;
Kumar et al. 1997, Abel et al. 2000, Krishnamurthy et al.
2000). These animals were fertile, but they showed that
FSH was required for normal development of Sertoli cell
and germ cell numbers (Kumar et al. 1997, Abel et al.
2000, Krishnamurthy et al. 2000). In addition, more
recent study of mice lacking both FSHR and AR on the
Sertoli cells showed that FSH acts to increase the number
of spermatogonia and the entryof these cells into meiosis
(Abel et al. 2008). From these studies, it was clear that
FSH was required for normal testicular development,
but it still remained uncertain how many of the effects of
FSH were mediated directly through FSH action and
how many were dependent on indirect alteration of
androgen levels. This study was designed, therefore, to
determine which effects of FSH on testicular function are
direct, which are dependent on androgen action and
whether those effects of androgen are mediated through
the Sertoli cell.
Sertoli cell numbers in the mouse are normally
determined by around post-natal day 15. Factors
regulating Sertoli cell number are not fully understood
but androgens, probably acting through the peritubular
myoid cells (PMCs), stimulate proliferation in utero,
while FSH is required post-natally (Johnston et al. 2004,
Tan et al.2 0 0 5 ). In the adult hpg mouse, Sertoli
cell numbers are about 50% of normal (Baker &
O’Shaughnessy 2001, Haywood et al. 2003), reﬂecting
the loss of both FSH and androgen post-natally in these
mice. Interestingly, there was a reduction in Sertoli cell
numbers in the hpg.ARKO mice compared with the
hpg. Androgen production by the hpg is minimal post-
natally but is normal in utero (O’Shaughnessy et al.
1998), and Sertoli cell numbers are normal at birth
(Baker & O’Shaughnessy 2001, Johnston et al. 2004).
This contrasts with ARKO or androgen-resistant Tfm
mice that have reduced Sertoli cell number at birth
(Johnston et al. 2004, Tan et al. 2005) suggesting that
differences in Sertoli cell numbers between hpg and
Figure 2 Semi-thin sections showing testicular morphology in
hpg, hpg.SCARKO and hpg.ARKO mice and in animals treated
with FSH. In untreated animals (A, C and E), spermatogenesis
was severely disrupted with only spermatogonia and some
spermatocytespresent.Inhpg.ARKO(E) mice, tubule diameter
was smaller and relative interstitial space was larger.
Treatment with FSH (B, D and F) increased tubule diameter
and germ cell numbers in all mice, although the effect was
most marked in the hpg. After FSH treatment, round
spermatids developed in hpg mice (yellow arrow, inset B)
but not in either hpg.SCARKO or hpg.ARKO mice
(insets D and F). Representative Sertoli cells and spermato-
cytes are indicated by black and white arrows respectively.
Photomicrographs are from semi-thin sections of testes ﬁxed
in paraformaldehyde/gluteraldehyde apart from the insets,
which are from Bouin’s-ﬁxed testes. The bar represents 20 mm.
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in the foetal testis. The number of Sertoli cells in
hpg. S C A R K Om i c ew a st h es a m ea si nt h ehpg,
consistent with data showing that SCARKO mice have
a normal contingent of Sertoli cells (De Gendt et al.
2004, Abel et al. 2008). This provides further conﬁr-
mation that androgen effects on Sertoli cell numbers are
independent of direct androgen action on the Sertoli cell
(Johnston et al. 2004, Tan et al. 2005). Failure of FSH to
affect Sertoli cell number in any group in this study is
consistent with earlier ﬁndings (O’Shaughnessy et al.
1992, Singh & Handelsman 1996) and indicates that the
Sertoli cells in the adult hpg are no longer sensitive to the
mitogenic effects of FSH.
Differences in germ cell numbers between untreated
hpg and hpg.ARKO mice could be due to the presence of
verylowlevelsof androgen in the post-natal hpg testis or,
as above, to the effects of androgen action in utero.
Androgen action in utero appears more likely since the
presence of endogenous testicular androgen post-natally
would probably lead to a difference in germ cell number
between hpg and hpg.SCARKO mice, as androgen
action through the Sertoli cell is clearly required for
normal germ cell development (De Gendt et al. 2004).
If the effects are due to androgen action in utero,
differences between hpg and hpg.SCARKO mice would
not arise since Sertoli cells do not express ARs until after
birth (Bremner et al. 1994, Zhou et al. 1996). In the foetal
testis, ARs are expressed predominantly on PMCs, which
would suggest that the differences in germ cell number
between adult hpg and hpg.ARKO mice are due to
androgen action through the PMCs in utero. Interest-
ingly, it has recently been shown that androgen action
through the PMCs is essential post-natally for the
development of normal spermatogenesis (Welsh et al.
2009). It has been reported that primordial germ cells
express the AR, which would offer an alternative mode of
action of androgens in utero (Merlet et al. 2007). The
direct effect of androgen on the germ cells is reported to
be inhibitory, however (Merlet et al. 2007), suggesting
that this is unlikely to explain differences between hpg
and hpg.ARKO mice.
Figure 3 Effect of FSH on (A) tubule diameter, (B) Sertoli cell number
and (C) Leydig cell number in hpg, hpg.SCARKO and hpg.ARKO mice.
An interaction indicates that the effect of FSH was signiﬁcantly different
in the three animal groups. In untreated animals, groups with different
letter superscripts were signiﬁcantly (P!0.05) different. If FSH had a
signiﬁcant effect on a particular animal group, this is indicated by *.
MeanGS.E.M. is shown. Animal numbers, hpg nZ6; hpgCFSH nZ3;
hpg.SCARKO nZ4; hpg.SCARKOCFSH nZ3; hpg.ARKO nZ3;
hpg.ARKOCFSH nZ3.
Figure 4 Effect of FSH on numbers of (A) total germ cell, (B)
spermatogonia, (C) spermatocytes and (D) round spermatids per testis
in hpg, hpg.SCARKO and hpg.ARKO mice. In untreated animals,
groups with different letter superscripts were signiﬁcantly different
(P!0.05). If FSH had a signiﬁcant effect on a particular animal group,
this is indicated by *. MeanGS.E.M. is shown. Animal numbers, hpg
nZ6; hpgCFSH nZ3; hpg.SCARKO nZ4; hpg.SCARKOCFSH nZ3;
hpg.ARKO nZ3; hpg.ARKOCFSH nZ3.
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different models including the hpg mouse, hpg mouse
expressing FSH, GNRH-immunised rat and hypophy-
sectomised rat, have reported that FSH acts to increase
the numbers of spermatogonia, spermatocytes and
round spermatids (Vihko et al. 1991, Bremner et al.
1994, McLachlan et al. 1995, Russell et al. 1998,
Haywood et al. 2003). In the hpg, hpg.SCARKO and
hpg.ARKO models, FSH increased the total germ cell
number and spermatogonial and spermatocyte num-
bers, consistent with earlier studies, and showed that
these effects of FSH are independent of androgen
action through the Sertoli cell or any other androgen-
responsive cell in the testis. FSH treatment also
stimulated round spermatid formation in the hpg testis,
as previously reported (Singh & Handelsman 1996,
Haywood et al. 2003), although spermatid numbers
were only about 5% of spermatocyte numbers. In
contrast, FSH failed to stimulate the generation of
round spermatids in the hpg.SCARKO and hpg.ARKO
mice showing that this effect of FSH is entirely
dependent on androgen action through the Sertoli
cells. This is consistent with earlier studies using
hypophysectomised rats, which showed that stimulation
of post-meiotic germ cell formation by FSH was partially
inhibited by the AR antagonist ﬂutamide (Russell et al.
1998) or ethane dimethane sulphonate, which acts to
destroy Leydig cells (Matikainen et al. 1994). One
caveat to these studies is that the hpg mice used here
will have developed in a gonadotrophin-free environ-
ment and may not, therefore, show the same response to
FSH as the normal adult animal. The consistency
between results using the hpg models and other data
described above using different animal models would
suggest, however, that these results are relevant to
normal spermatogenesis. Overall, therefore, the results
from this and earlier studies show that, in rodents FSH
acts to stimulate spermatogenesis through an increase in
spermatogonial number and subsequent entry of these
cells into meiosis. Completion of meiosis appears to be
absolutely dependent on the action of androgen.
Generally, insofar as it has been studied, the effects of
FSH appear to be similar across different mammalian
species. In rhesus and cynomolgus monkeys, FSH
appears to act primarily to increase the number of
spermatogonia (Marshall et al. 1986, 1995, Simorangkir
et al. 2009), while in sheep immunisation against FSH
reduces spermatogonial numbers (Kilgour et al.1998).
The role of FSH in human spermatogenesis remains
somewhat unclear since there is a conﬂict between the
effects of FSHb deletion and FSHR deletion (Tapanainen
et al. 1997, Lindstedt et al. 1998, Phillip et al. 1998,
Layman et al. 2002) and because treatment of infertile
hypogonadotrophic men is based on treatment with
hCG making it difﬁcult to establish effects of FSH.
Nevertheless, the prevailing evidence suggests that
data from rodents are relevant generally and that the
primary effect of FSH is to maintain spermatogenesis
quantitatively through effects on spermatogonial numbers.
Numerous studies have shown that FSH will stimulate
Leydig cell function through an indirect mechanism,
which is assumed to involve release of paracrine factors
from the Sertoli cells following direct stimulation of the
FSH receptor (Chen et al. 1976, Vihko et al. 1991). In this
study, intratesticular testosterone levels were only
increased by FSH in the hpg group and not the
hpg.SCARKO or hpg.ARKO groups. This contrasts with
the increase in seminal vesicle weights after FSH
treatment in both hpg and hpg.SCARKO groups
suggesting that there is an increase in testosterone in
the hpg.SCARKO at the start of treatment, but that this is
not maintained up to 7 days. Baines et al. (2008) have
shown previously that FSH will increase Leydig cell
number in the adult hpg. Our results conﬁrm this
observation and show that the effects of FSH on Leydig
cell number in the hpg mouse are mediated through
androgen action not involving the Sertoli cells. Since
Leydig cells express ARs (Zhou et al. 2002), the simplest
explanation is that FSH indirectly stimulates androgen
production by the Leydig cells, which, in turn, acts
directly on the Leydig cells to induce proliferation or,
possibly, differentiation from precursor stem cells. This
is consistent with earlier data showing that Leydig
cell number is reduced in Tfm and ARKO mice
(O’Shaughnessy et al. 2002, De Gendt et al. 2005).
In conclusion, the design of this study has allowed us
to dissect the direct effects of FSH away from those of
androgen and to show that FSH acts only during the
initial stages of spermatogenesis to optimise germ cell
number. Results also demonstrate that FSH cannot
stimulate completion of meiosis, which is entirely
dependent on androgen action.
Materials and Methods
Animals and treatments
All mice were bred and all procedures carried out under UK
Home Ofﬁce Licence and with the approval of a local ethical
review committee. SCARKO and ARKO mice have been
previously generated by crossing female mice carrying an Ar
with a ﬂoxed exon 2 (Ar
ﬂ) with male mice expressing Cre under
the regulation of the Sertoli cell-speciﬁc promoter Amh or the
ubiquitous promoter Pgk1 (Lecureuil et al. 2002, De Gendt
et al. 2004). In order to produce hpg.SCARKO mice, hpg
mice (C3HE/HeH-101/H) were initially crossed with mice
carrying the Ar
ﬂ allele (Swiss-Webster/129) and with mice
carrying the Amh-Cre transgene (C57-BL6/SJL). From these
crosses, female mice heterozygous for the GNRH deletion
(hpg/C) and homozygous for the Ar
ﬂ allele were crossed with
hpg/CAmh-Cre males (heterozygous or homozygous for Cre)
to generate hpg.SCARKO mice. The hpg deletion and Ar
ﬂ allele
were detected by PCR analysis of ear clip lysates (Lang 1991)
and excision of the ﬂoxed Ar conﬁrmed at termination by PCR
of testicular DNA (De Gendt et al. 2004). The generation of
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replaced Amh-Cre.T h ehpg.ARKO males were detected by
PCR of ear clip lysates for Sry and deletion of GNRH and
conﬁrmed at termination by the absence of epididymides,
seminal vesicles and ductus deferens. The hpg mice used in this
study were generated from the same litters producing
hpg.SCARKO and hpg.ARKO mice.
To determine the effects of FSH treatment, adult (10 weeks of
age) male hpg, hpg.SCARKO and hpg.ARKO mice were
injected s.c. with 8 IU recombinant human FSH (Serono Ltd)
in 0.2 ml PBS (pH 7.4, Sigma–Aldrich) once daily for 7 days.
The manufacturer’s datasheet states that the hormone prepa-
ration contains no LH activity. The dose used was based on
preliminary dose–response studies showing that 8 IU/day
caused a maximum increase in testis weight over a 1-week
period. Mice were killed on day 8 (24 h after the last injection),
and testes were snap frozen in liquid nitrogen or ﬁxed
overnight. Fixation was either in Bouin’s for subsequent
morphometric analysis or 4% paraformaldehyde/1% gluter-
aldehyde in phosphate buffer (0.1 M, pH 7.4) for preparation of
semi-thin sections.
Testicular morphology in the hpg mouse has been described
previously in a number of publications (Cattanach et al. 1977,
Singh & Handelsman 1996, Myers et al. 2005, Lim et al. 2008).
Spermatogenesis can progress to the pachytene spermatocyte
stage in the hpg mouse, and numbers of spermatocytes and
spermatogonia are similar (Singh & Handelsman 1996, Myers
et al. 2005, Lim et al. 2008). In the hpg mice produced for this
study, w80% were of this phenotype but the remaining 20% of
animals had !5% of the expected number of spermatocytes
present. All the mice used in this study are generated by
crossing mouse lines that are on different backgrounds, and it
appears likely that the altered phenotype in some animals is
caused by background effects. Mice with a clear, marked
reduction in spermatocyte numbers were not used in the study
reported here.
Hormone measurements
Intratesticular levels of testosterone were measured by RIA
following ethanol extraction, as previously described
(O’Shaughnessy & Shefﬁeld 1990). The limit of detection of
the assay was 40 fmol/ml, which equates to 20 fmol/testis after
extraction. The intra- and inter-assay coefﬁcients of variation
were 6.8 and 12.1% respectively. Cross reactivity with
androstenedione and 5a-androstane-3a,17b-diol was 3.0 and
8.1% respectively.
Histology and stereology
To prepare semi-thin (1 mm) sections, testes were embedded in
araldite and sections were stained with toluidine blue. For
stereological analysis, testes were embedded in Technovit
7100 resin, cut into sections (20 mm) and stained with Harris’s
haematoxylin. The total testis volume was estimated using the
Cavalieri principle (Mayhew 1992). The optical disector
technique (Wreford 1995) was used to count the number of
Sertoli cells, germ cells and Leydig cells in each testis. Each
cell type was identiﬁed by previously described criteria
(Russell et al. 1990, Baker & O’Shaughnessy 2001). The
numerical density of each cell type was estimated using an
Olympus BX50 microscope ﬁtted with a motorised stage (Prior
Scientiﬁc Instruments, Cambridge, UK) and Stereologer soft-
ware (Systems Planning Analysis, Alexandria, VA, USA).
Tubule diameter was measured directly in a total of at least
36 tubules from three sections.
Statistical analysis
Most data sets were analysed using two-factor ANOVA with
effects of FSH and AR deletion as the factors. Where the
interaction between factors was signiﬁcant, this indicates
that the effect of FSH was altered by deletion of the AR.
To determine whether differences between individual groups
were signiﬁcant, t-tests were employed using the pooled
variance from the ANOVA. Data were log transformed where
appropriate to avoid heterogeneity of variance. Data on intra-
testicular testosterone were analysed by the non-parametric
Kruskal–Wallis test followed by the Mann–Whitney test.
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